CS
PALI icon

Credit Suisse’s Palisade Bio PALI Stock Holding History

Credit Suisse’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– – – 4084
2022
Q3 		– Hold
0
– – – 4212
2022
Q2 		– Hold
0
– – – 4202
2015
Q4 		– Hold
0
– -$513K – 4326
2015
Q3 		– Sell
-1
Closed -$1.84M – 3366
2015
Q2 		$1.19M Buy
+1
New +$2.18M ﹤0.01% 3011
2015
Q1 		– Hold
0
– – – 3166
2014
Q4 		– Hold
0
– – – 2982
2014
Q3 		– Hold
0
– – – 2751
2014
Q2 		– Sell
-1
Closed -$4.7M – 2792
2014
Q1 		$2.58M Buy
+1
New +$4.14M ﹤0.01% 2323
2013
Q4 		– Hold
0
– – – 2882
2013
Q3 		– Hold
0
– – – 2672
2013
Q2 		– Hold
0
– – – 2983

Other funds holding PALI

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Credit Suisse's PALI Position: Q4 2022 in Review

Credit Suisse held its Palisade Bio (PALI) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4084.

Credit Suisse first reported a position in PALI in Q1 2014 and has held it in 2 quarters since. The position peaked at $2.58M in Q1 2014. 11 funds tracked by Wall St. Rank hold PALI as of Q4 2022.

  • Credit Suisse held 0 shares of Palisade Bio worth $0 as of Q4 2022.
  • Credit Suisse left its Palisade Bio share count unchanged in Q4 2022.
  • Palisade Bio made up ﹤0.01% of Credit Suisse's portfolio in Q4 2022, its #4084 holding.
  • Credit Suisse first reported a position in Palisade Bio in Q1 2014 and has held it in 2 quarters since.
  • Credit Suisse's Palisade Bio position peaked at $2.58M in Q1 2014.
  • 11 funds tracked by Wall St. Rank held Palisade Bio as of Q4 2022.

Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.